[Role of Neurologists in Dementia Practice].

Brain Nerve

Department of Behavioral Neurology and Neuropsychiatry, Osaka University.

Published: August 2024

AI Article Synopsis

  • The article highlights the crucial role of neurologists in dementia care, emphasizing their need for proactive leadership in interdisciplinary teams with general practitioners and psychiatrists.
  • Advances like the introduction of the anti-Alzheimer drug lecanemab necessitate neurologists to adopt a more involved approach, leading to the rise of "novice" dementia specialists.
  • A significant shortage of neurologists skilled in behavioral neurology presents a challenge in Japan, stressing the urgent need for improved education and specialization to enhance dementia management.

Article Abstract

The September 2013 issue of this journal contains an article titled "The Role of Neurologists in Dementia Practice" in which I have highlighted the contributions of neurologists to dementia care. I have emphasized the importance of proactive leadership within interdisciplinary teams that include general practitioners and psychiatrists. Following the implementation of the Basic Act on Dementia to Promote an Inclusive Society and advances in medical science, such as introduction of the anti-Alzheimer drug lecanemab, neurologists are expected to play a more active role in dementia management and require more specialized skills. The emergence of lecanemab has led to more direct involvement of neurologists in dementia practice, which has resulted in the emergence of "novice" dementia specialists. However, a shortage of neurologists who specialize in behavioral neurology remains a significant concern in Japan. This challenge is compounded by the inadequate education of general neurologists in this domain, because dementia management requires deep knowledge and skills in behavioral neurology. The most important and urgent issue is to promptly address this shortage. Although neurologists' involvement in dementia practice is attributable to the introduction of lecanemab, I sincerely look forward to neurologists transitioning from "novice" to "real" experts in dementia. I reiterate this call as a recommendation to fellow neurologists, emphasizing the need to evolve into true specialists in the field.

Download full-text PDF

Source
http://dx.doi.org/10.11477/mf.1416202706DOI Listing

Publication Analysis

Top Keywords

neurologists dementia
16
dementia
10
neurologists
8
dementia management
8
dementia practice
8
behavioral neurology
8
[role neurologists
4
dementia practice]
4
practice] september
4
september 2013
4

Similar Publications

Prevalence of dementia among Indigenous populations of countries with a very high Human Development Index: a systematic review.

Lancet Healthy Longev

December 2024

School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.

Dementia is a health priority for Indigenous peoples. Here, we reviewed studies on the prevalence of dementia or cognitive impairment among Indigenous populations from countries with a very high Human Development Index (≥0·8). Quality was assessed using the Joanna Briggs Institute risk-of-bias tool and CONSolIDated critERia for strengthening the reporting of health research involving Indigenous peoples (CONSIDER), with oversight provided by an Indigenous Advisory Board.

View Article and Find Full Text PDF

Objective: To evaluate the cognitive abilities of the leading large language models and identify their susceptibility to cognitive impairment, using the Montreal Cognitive Assessment (MoCA) and additional tests.

Design: Cross sectional analysis.

Setting: Online interaction with large language models via text based prompts.

View Article and Find Full Text PDF

Anti-amyloid treatments for Alzheimer's disease: A study on physicians' perspectives.

J Alzheimers Dis

December 2024

Cognitive Neurology Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.

Advances in amyloid targeting therapies (ATT) for Alzheimer's disease have introduced new options, necessitating an understanding of physicians' perspectives as these therapies move from trials to practice. A survey of Israeli specialists found that 84% were familiar with new ATT, but 60% raised doubts about their ability to significantly impact disease progression. Neurologists were more likely to recommend these treatments, but concerns included treatment costs and limited real-world experience.

View Article and Find Full Text PDF

Determinants of Time to Diagnosis in Young-Onset Dementia.

Am J Alzheimers Dis Other Demen

December 2024

Department of Anatomy and Medical Imaging, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand.

Timely diagnosis of young-onset dementia (YOD) is critical. This study aimed to identify factors that increased time to diagnosis at each stage of the diagnostic pathway. Participants were patients diagnosed with YOD (n = 40) and their care partners (n = 39).

View Article and Find Full Text PDF

Objective: Alzheimer's disease (AD) is a leading cause of dementia, with a rising global burden. Remnant cholesterol (RC), a component of triglyceride-rich lipoproteins, has been implicated in cardiovascular diseases and metabolic disorders, but its role in AD remains unclear. This study investigated the association between RC levels and the risk of AD among elderly patients with type 2 diabetes (T2D) in a real-world clinical setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!